Detection of (11; 22)(q24;q12) Translocation-Bearing Cells in Peripheral Blood Progenitor Cells of Patients With Ewing's Sarcoma Family of Tumors
|
journal
|
March 1995 |
T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients
|
journal
|
February 1996 |
In vivo tracking of tumor-specific T cells
|
journal
|
April 2001 |
Uses of monoclonal antibody 8H9
|
patent
|
August 2013 |
Surface Antigen Expression and Complement Susceptibility of Differentiated Neuroblastoma Clones
|
journal
|
March 2000 |
SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2
|
journal
|
January 1994 |
Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes.
|
journal
|
September 1993 |
Desmoplastic Small Round Cell Tumor: II: An Ultrastructural and Immunohistochemical Study with Emphasis on New Immunohistochemical Markers
|
journal
|
January 1998 |
Comparison of purity and enrichment of CD34 + cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems
|
journal
|
January 1995 |
Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy: Quantitative imaging of I-124
|
journal
|
May 1991 |
Intra-abdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural, and flow cytometric study
|
journal
|
August 1993 |
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma
|
journal
|
May 1993 |
New monoclonal antibodies specific for human sarcomas
|
journal
|
July 1986 |
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
|
journal
|
June 1997 |
The Diagnostic Utility of Desmin: A Study of 584 Cases and Review of the Literature
|
journal
|
March 1990 |
Ewing Family Tumors: Potential Prognostic Value of Reverse-Transcriptase Polymerase Chain Reaction Detection of Minimal Residual Disease in Peripheral Blood Samples
|
journal
|
January 1998 |
Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas
|
journal
|
November 1993 |
Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients
|
journal
|
January 1995 |
Diagnostic imaging of human neuroblastoma with radiolabeled antibody.
|
journal
|
November 1986 |
A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2
|
journal
|
May 1991 |
High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors
|
journal
|
December 1997 |
Immunocytokines: A Promising Approach to Cancer Immunotherapy
|
journal
|
December 1998 |
Functional expression of chimeric receptor genes in human T cells
|
journal
|
February 2001 |
Role of High-Dose Chemotherapy With Hematopoietic Stem Cell Rescue in the Treatment of Metastatic or Recurrent Rhabdomyosarcoma
|
journal
|
January 2001 |
Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
|
patent
|
December 1993 |
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.
|
journal
|
March 1994 |
Phage Library-derived Human Anti-TETA and Anti-DOTA ScFv for Pretargeting RIT
|
journal
|
February 1999 |
Monoclonal antibody against ependymoma-derived cell line
|
journal
|
January 1992 |
Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays
|
journal
|
August 1989 |
Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics
|
journal
|
December 1999 |
A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a
|
journal
|
May 1992 |
Intergroup Rhabdomyosarcoma Study: Update for Pathologists
|
journal
|
November 1998 |
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
|
journal
|
November 1979 |
Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross-organ beta doses
|
journal
|
January 1996 |
Characteristics of the cell surface antigen, p72, associated with a variety of human tumours and mitogen-stimulated T-lymphoblasts
|
journal
|
June 1984 |
Human Glioma-Specific Antigens Detected by Monoclonal Antibodies
|
journal
|
January 1992 |
Continuous cultures of fused cells secreting antibody of predefined specificity
|
journal
|
August 1975 |
Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy
|
journal
|
July 1997 |
Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy
|
journal
|
June 1997 |
Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry
|
journal
|
January 1993 |
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma
|
journal
|
November 1998 |
A Monte Carlo approach to patient-specific dosimetry
|
journal
|
September 1996 |
Humanized immunoglobulins
|
patent
|
December 1997 |
Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene
|
journal
|
August 1994 |
Pharmacokinetics and acute toxicology of intraventricular 131I-monoclonal antibody targeting disialoganglioside in non-human primates
|
journal
|
January 1997 |
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
|
journal
|
January 1993 |
Method for preparation of single chain antibodies
|
patent
|
April 2012 |
Biotechnological and gene therapeutic strategies in cancer treatment
|
journal
|
June 1995 |
Clinical Applications of CD34 + Peripheral Blood Progenitor Cells (PBPC)
|
journal
|
March 2000 |
131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II Study
|
journal
|
January 1999 |
Monoclonal antibody against human glioblastoma multiforme (U-87MG) immunoprecipitates a protein of molecular mass 38 kDa and inhibits tumor growth in nude mice
|
journal
|
January 1995 |
Immunogenic peptides of prostate specific antigen
|
patent
|
December 2001 |
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.
|
journal
|
January 1993 |
Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes
|
journal
|
August 1998 |
Impact of chimeric immune receptor extracellular protein domains on T cell function
|
journal
|
March 1999 |
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations
|
journal
|
April 1997 |
CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma
|
journal
|
June 2000 |
Autologous stem cell transplantation for high-risk pediatric solid tumors
|
journal
|
September 1999 |
Efficient Discrimination between Different Densities of Target Antigen by Tetracycline-Regulatable T Bodies
|
journal
|
March 1999 |
Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells
|
journal
|
March 1995 |
Yttrium-90 biodistribution by yttrium-87 imaging: A theoretical feasibility analysis
|
journal
|
August 1998 |
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
|
journal
|
November 1999 |
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report
|
journal
|
January 1995 |
Uses of monoclonal antibody 8H9
|
patent
|
April 2013 |
Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
|
journal
|
February 1996 |
Radionuclide photon dose kernels for internal emitter dosimetry
|
journal
|
May 1996 |
Multi-stage cascade boosting vaccine
|
patent
|
October 2000 |
Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy
|
book
|
January 1994 |
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
|
journal
|
April 1988 |
Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues
|
journal
|
September 2000 |
Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells
|
journal
|
November 1997 |
Detection of Prostatic Specific Membrane Antigen Messenger RNA Using Immunobead Reverse Transcriptase Polymerase Chain Reaction
|
journal
|
January 1999 |
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma
|
journal
|
January 1995 |
Hexabrachion Protein (Tenascin, Cytotactin, Brachionectin) in Connective Tissues, Embryonic Brain, and Tumors
|
journal
|
January 1988 |
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
|
journal
|
November 1997 |
The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y
|
journal
|
June 1991 |
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain
|
journal
|
July 1993 |
Multimodality Diagnostics and Megatherapy in Poor Prognosis Ewing's Tumor Patients
|
journal
|
October 1999 |
Common Musculoskeletal Tumors of Childhood and Adolescence
|
journal
|
July 1999 |
Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours
|
journal
|
August 1999 |
Radiotherapy and High-Dose Chemotherapy in Advanced Ewing's Tumors
|
journal
|
October 1999 |
Radioimmunotherapy with alpha-emitting nuclides
|
journal
|
September 1998 |
Disialoganglioside GD2 anti-idiotypic monoclonal antibodies
|
journal
|
May 1993 |
Expression of CD44 splice variants in human primary brain tumors
|
journal
|
December 1995 |
Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR: Monitoring of MRD by Real-time Quantitation
|
journal
|
August 1998 |
Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor
|
journal
|
July 1990 |
Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same
|
patent
|
October 2003 |